Literature DB >> 9460989

Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione.

K Barnouin1, I Leier, G Jedlitschky, A Pourtier-Manzanedo, J König, W D Lehmann, D Keppler.   

Abstract

The human multidrug resistance protein (MRP1) confers resistance of cells to a number of different cytostatic drugs and functions as an export pump for glutathione S-conjugates, glucuronides and other amphiphilic anions. The present study details for the first time MRP1-mediated ATP-dependent transport of various glutathione S-conjugates of the bifunctional alkylating agents chlorambucil and melphalan. In membrane vesicles prepared from cells expressing recombinant MRP1, the conjugates were transported at rates in the following order: monoglutathionyl chlorambucil > bisglutathionyl chlorambucil > monohydroxy monoglutathionyl chlorambucil and monoglutathionyl melphalan > monohydroxy monoglutathionyl melphalan. In addition, we show that membranes from chlorambucil-resistant GST-alpha-overexpressing CHO cells as well as from their parental cells express the hamster homologue of MRP1. With both CHO cell membrane preparations, we observed ATP-dependent transport of monoglutathionyl chlorambucil and of leukotriene C4, a glutathione S-conjugate and high-affinity substrate of MRP1. The transport rates measured in the resistant cells were only two- to three-fold higher than those measured in the control cells. These results together with cytotoxicity assays comparing MRP1-overexpressing cell pairs with the CHO cell pair indicate that, although MRP1-mediated transport is active, it may not be the rate-limiting step in chlorambucil resistance in these cell lines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9460989      PMCID: PMC2151220          DOI: 10.1038/bjc.1998.34

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  38 in total

Review 1.  Biology of the multidrug resistance-associated protein, MRP.

Authors:  D W Loe; R G Deeley; S P Cole
Journal:  Eur J Cancer       Date:  1996-06       Impact factor: 9.162

Review 2.  Glutathione and related enzymes in multidrug resistance.

Authors:  M L O'Brien; K D Tew
Journal:  Eur J Cancer       Date:  1996-06       Impact factor: 9.162

3.  Analytical properties of the nanoelectrospray ion source.

Authors:  M Wilm; M Mann
Journal:  Anal Chem       Date:  1996-01-01       Impact factor: 6.986

Review 4.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.

Authors:  J D Hayes; D J Pulford
Journal:  Crit Rev Biochem Mol Biol       Date:  1995       Impact factor: 8.250

5.  Characterization of melphalan-glutathione adducts whose formation is catalyzed by glutathione transferases.

Authors:  D M Dulik; C Fenselau; J Hilton
Journal:  Biochem Pharmacol       Date:  1986-10-01       Impact factor: 5.858

Review 6.  Cellular pharmacokinetics of the phenylalanine mustards.

Authors:  D T Vistica
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

7.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

8.  Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter.

Authors:  B D Stride; G Valdimarsson; J H Gerlach; G M Wilson; S P Cole; R G Deeley
Journal:  Mol Pharmacol       Date:  1996-06       Impact factor: 4.436

9.  Uptake and decomposition of chlorambucil by L5178Y lymphoblasts in vitro.

Authors:  A Begleiter; G J Goldenberg
Journal:  Biochem Pharmacol       Date:  1983-02-01       Impact factor: 5.858

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  14 in total

1.  The extended-MDR phenotype.

Authors:  R Davey; M Davey
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

2.  A fluorometric screening assay for drug efflux transporter activity in the blood-brain barrier.

Authors:  Corbin J Bachmeier; Donald W Miller
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

3.  ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.

Authors:  J Renes; E G de Vries; E F Nienhuis; P L Jansen; M Müller
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 4.  Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1).

Authors:  Eva Bakos; László Homolya
Journal:  Pflugers Arch       Date:  2006-12-23       Impact factor: 3.657

Review 5.  Development of multidrug-resistance convertors: sense or nonsense?

Authors:  L van Zuylen; K Nooter; A Sparreboom; J Verweij
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

6.  Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan.

Authors:  Kavindra Nath; David S Nelson; Daniel F Heitjan; Rong Zhou; Dennis B Leeper; Jerry D Glickson
Journal:  NMR Biomed       Date:  2015-03       Impact factor: 4.044

7.  Protection of HepG2 cells against acrolein toxicity by 2-cyano-3,12-dioxooleana-1,9-dien-28-imidazolide via glutathione-mediated mechanism.

Authors:  Halley Shah; Adam M Speen; Christina Saunders; Elizabeth A S Brooke; Palanisamy Nallasamy; Hong Zhu; Y Robert Li; Zhenquan Jia
Journal:  Exp Biol Med (Maywood)       Date:  2014-12-11

8.  Nrf2 Regulates the Sensitivity of Mouse Keratinocytes to Nitrogen Mustard via Multidrug Resistance-Associated Protein 1 (Mrp1).

Authors:  Ronald G Udasin; Xia Wen; Kristin M Bircsak; Lauren M Aleksunes; Michael P Shakarjian; Ah-Ng Tony Kong; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2015-10-09       Impact factor: 4.849

Review 9.  Multidrug resistance: Physiological principles and nanomedical solutions.

Authors:  Sijumon Kunjachan; Błażej Rychlik; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

10.  Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP).

Authors:  D R Hipfner; M Gao; G Scheffer; R J Scheper; R G Deeley; S P Cole
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.